Publications of Christoph Rademacher
All genres
Journal Article (70)
1.
Journal Article
Drug-like inhibitors of DC-SIGN based on a quinolone scaffold. ACS Medicinal Chemistry Letters (2022)
2.
Journal Article
5 (5), pp. 2185 - 2192 (2022)
Synthetic glyconanoparticles modulate innate immunity but not the complement system. ACS applied bio materials 3.
Journal Article
61 (1), e202109339 (2022)
Druggable allosteric sites in β-propeller lectins. Angewandte Chemie International Edition 4.
Journal Article
23 (3), e202100563 (2022)
Targeting the central pocket of the Pseudomonas aeruginosa lectin LecA. Chembiochem 5.
Journal Article
141 (1), pp. 84 - 94.e6 (2021)
Notch-mediated generation of monocyte-derived Langerhans cells: phenotype and function. Journal of Investigative Dermatology 6.
Journal Article
60 (24), pp. 13302 - 13309 (2021)
Automated glycan assembly of 19F labelled glycan probes enables high‐throughput NMR studies of protein‐glycan interactions. Angewandte Chemie International Edition 7.
Journal Article
7 (3), pp. 624 - 635 (2021)
Impact of glycan linkage to staphylococcus aureus wall teichoic acid on langerin recognition and Langerhans cell activation. ACS Infectious Diseases 8.
Journal Article
296, 100718 (2021)
The molecular basis for the pH-dependent calcium affinity of the pattern recognition receptor langerin. The Journal of Biological Chemistry 9.
Journal Article
60 (15), pp. 8104 - 8114 (2021)
Non-carbohydrate glycomimetics as inhibitors of calcium(II)-binding lectins. Angewandte Chemie International Edition 10.
Journal Article
12, 732298 (2021)
Specific protein antigen delivery to human Langerhans cells in intact skin. Frontiers in immunology 11.
Journal Article
31 (2), pp. 159 - 165 (2021)
Protein-observed 19F NMR of LecA from Pseudomonas aeruginosa. Glycobiology 12.
Journal Article
143 (45), pp. 18977 - 18988 (2021)
A remote secondary binding pocket promotes heteromultivalent targeting of DC-SIGN. Journal of the American Chemical Society 13.
Journal Article
59 (47), pp. 21016 - 21022 (2020)
Rational design of an DNA-scaffolded high-affinity binder for langerin. Angewandte Chemie International Edition 14.
Journal Article
62, pp. 31 - 38 (2020)
Allostery in C-type lectins. Current Opinion in Structural Biology 15.
Journal Article
26 (44), pp. 9954 - 9963 (2020)
On-chip neo-glycopeptide synthesis for multivalent glycan presentation. Chemistry – A European Journal 16.
Journal Article
63 (23), pp. 14780 - 14804 (2020)
From pyrazolones to azaindoles: evolution of active-site SHP2 inhibitors based on scaffold hopping and bioisosteric replacement. Journal of Medicinal Chemistry 17.
Journal Article
59 (6), pp. 2204 - 2210 (2020)
The 3F library: fluorinated Fsp3-rich fragments for expeditious 19F-NMR-based screening. Angewandte Chemie, International Edition 18.
Journal Article
12 (2), pp. 191 - 200 (2020)
A common genetic variation in Langerin (CD207) compromises cellular uptake of Staphylococcus aureus. Journal of Innate Immunity 19.
Journal Article
7, 215 (2019)
Ranking Hits From Saturation Transfer Difference Nuclear Magnetic Resonance–Based Fragment Screening. Frontiers in Chemistry 20.
Journal Article
2, 450 (2019)
Repression of phagocytosis by human CD33 is not conserved with mouse CD33. Communications Biology